NACUITY - Key Persons


Benjamin R. Yerxa

Job Titles:
  • CEO, Opus Genetics / Former CEO, Foundation Fighting Blindness and RD Fund / Former President and Chief Scientific Officer, Envisia Therapeutics

Charles Lieser

Job Titles:
  • CFO / Owner, Weaver, LLP, 32 Yrs

Daniel Feller

Job Titles:
  • Owner and CEO, Talisman Healthcare / COO, GEM42S Ltd

David Birch

Job Titles:
  • Scientific Director, Retina Foundation of the Southwest / Director, Rose - Silverthorne Retinal Degenerations Laboratory

David Wohlberg - Founder

Job Titles:
  • Co - Founder

Douglas G. Johnson

Job Titles:
  • President, OCAM Solutions, Inc. Consultant, Chemistry and Manufacturing
Consultant, Chemistry and Manufacturing. Over 20 years of experience in the pharmaceutical industry Previously led chemistry and manufacturing for 10+ years at Allos Therapeutics where he was Vice President of Manufacturing and Vice President of Pharmaceutical Sciences

Frances Kane

Job Titles:
  • President of Apropos Pharmaceutical Consulting, LLC. Consultant, Regulatory Affairs and Clinical Science
Extensive experience in the pharmaceutical industry, with a wide range of experience in regulatory, project management, clinical and preclinical functions Dissertation research examined the effects of diabetes mellitus on the retina. Led preparation of clinical portions of NDA for AMD at Alcon

G. Michael Wall - CSO, SVP

Job Titles:
  • CSO
  • SVP
22 years at Alcon Laboratories, directing all phases of ophthalmic, otic, nasal drug development, numerous products

Halden Conner - CEO, Chairman, Founder

Job Titles:
  • CEO
  • Chairman
  • Co - Founder
  • Chairman, CEO, Co - Founder, Nacuity Pharmaceuticals, Inc.

Jami R. Kern - CCO, SVP

Job Titles:
  • CCO
  • SVP

Lee Anderson

Job Titles:
  • Ophthalmologist in Residence

Mark Pennesi

Job Titles:
  • Professor and Chief of Ophthalmic Genetics, Casey Eye Institute

Nancy Holekamp

Job Titles:
  • Professor of Clinical Ophthalmology and Visual Sciences, Washington University School of Medicine / Director of Retina Services, Pepose Vision Institute

Onkar Singh

Job Titles:
  • Formulations Consultant, President, OS Pharma Consulting, LLC / VP, Alentia Therapeutics ( Solid Oral Dosage - Neurodegeneration )

Russell Kelley

Job Titles:
  • Managing Director, Retinal Degeneration Fund / Former Scientist, Director and Head of Preclinical, Tengion / Director, Opus Genetics and SparingVision

Scott Dorfman

Job Titles:
  • Co - Founder, CEO and Chairman, Odylia Therapeutics / Founder, Former Chairman and CEO of Innotrac Corporation

Tim Stout

Job Titles:
  • Director, Cullen Eye Institute, Baylor College of Medicine / Chair, Department of Ophthalmology, Baylor College of Medicine